ARCHIVES

FIT More Effective Than gFOBT In All Colonoscopy Capacities

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | November 25, 2011

Download PDF Visit The Full Archive

Related Articles

NCI, Rhone-Poulenc Sign Agreement For Taxotere Trials

June 19, 1992

CMS also decided to cover off-label uses of approved colorectal cancer drugs in clinical trials, and allowed broader use of PET scans.

November 5, 2004

In Brief: JNCI Article Describes Advances Pancreatic Cancer; Preventative Oncology Society Formed

August 13, 1976

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

DCCR Advisors Okay New Programs; $300,000 Year Demonstrations In Six Communities Supported

November 17, 1978